• Keine Ergebnisse gefunden

Supplementary Table S1

N/A
N/A
Protected

Academic year: 2022

Aktie "Supplementary Table S1"

Copied!
6
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Supplementary Table S1. Point assignment of prognostic scores

Variable Prognostic Score Age, y

< 60 60-70

> 70

0 2.190 3.631 Sex

Female Male

0 1.414 Surgery

Lobectomy Sublobectomy

Pneumonectomy

0 1.372 1.298 T stage

T1a T1b T1c T2a T2b T3 T4

0 1.174 1.479 2.432 2.781 3.306 3.618 LND

0-5 6-10 11-20 21-30 > 30

3.244 2.355 1.383 1.073 0 LNM

0 1-3 4-6 7-9 >= 10 NO*

0 2.994 4.800 6.006 10.000 1.898 Chemotherapy

No/Unknown Yes

1.647 0

LND, lymph node dissected; LNM, lymph node metastasis; NO*, no lymph node dissected.

1

2 3

(2)

Supplementary Table S2. Univariate analysis for patients with N0, N1, and N2 disease in the training and validation cohort.

Training cohort Validation cohort

N0 N1 N2 N0 N1 N2

Variables HR (95%

CI)

P value

HR (95%

CI)

P value

HR (95%

CI)

P value

HR (95%

CI)

P value

HR (95%

CI)

P value

HR (95%

CI)

P Value Chemotherapy

(Yes vs.

No/Unknown)

0.789 (0.646- 0.963)

0.020 0.760 (0.528- 1.096)

0.142 0.441 (0.312- 0.624)

< 0.001 0.551 (0.238- 1.276)

0.164 0.666 (0.287- 1.544)

0.344 0.151 (0.070- 0.327)

< 0.001

Radiotherapy

(Yes vs.

No/Unknown)

0.990 (0.792- 1.239)

0.932 0.768 (0.569- 1.037)

0.085 0.675 (0.501- 0.908)

0.009 2.418 (1.288- 4.539)

0.006 0.992 (0.586- 1.680)

0.975 0.558 (0.361- 0.861)

0.008 1

2 3 4 5 6 7

(3)

Supplementary Figure S1. Flow chart for enrollment of the SEER database

SCLC, small cell lung cancer; NOS, not otherwise specified.

1

2 3

(4)

Supplementary Figure S2. Kaplan-Meier survival curves in the univariate analysis.

SCLC, small cell lung cancer; LND, lymph node dissected; LNM, lymph node metastasis; NO*, no lymph node dissected.

Supplementary Figure S3. The optimal cutoff values for risk scores determined by

1

2 3 4 5

(5)

X-tile software (Yale University, New Haven, CT, USA) in patients of the training

cohort.

Risk score groups were developed using the primary outcome of OS.

Supplementary Figure S4. Online calculator interface for our nomogram. The left

side showed this input field and run button. The right side showed the corresponding output figure and table (A, survival curve; B and C, estimated survival probability and 95% confidence interval).

1

2 3 4 5 6 7

(6)

1

Referenzen

ÄHNLICHE DOKUMENTE

Patient effective dose from sentinel lymph node lymphoscintigraphy in breast can- cer: a study using a female humanoid phantom and thermolumi-

In addition, IL-7 might sensitize Treg cells and facilitate their recognition of IL-2, leading to Treg cell expansion and better suppression of effector T cell

I show in the second part of this thesis, that TSLP overexpression increased LTi cell number and restored LN development in IL-7 -/- and RAG2 -/- γ c -/- mice, suggesting that

Die Erfahrung mit dieser Methode bei mali- gnen Melanomen zeigt eine hohe Sensitivität (95 bis 100 Prozent) für die Darstellung des „Sentinel Lymph Node“ (6, 9, 14).. Nach

1 Department of Radiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of

The purpose of this study was to increase the awareness and reveal the potential of parotid metastasis of oral squamous cell carcinoma (OSCC), describe the characteristic of

Deswegen wurde für die 3 positiven Substanzen, bei denen die Stimulationsindices für die getesteten Konzentrationen alle über 3 lagen, versucht, näherungsweise einen „EC 3 -analogen

In a study on the topographi- cal distribution of SLNs and non-SLN metastases in 220 patients with early-stage OSCC and lymph node metastases, 53 patients had positive SLNB